Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Robb

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983
Purification and partial sequence analysis of human T-cell growth factorR J Robb, R M Kutny, V Chowdhry
The Journal of Experimental Medicine|November 1, 1981
T cell growth factor receptors. Quantitation, specificity, and biological relevanceR J Robb, A Munck, K A Smith
Journal of Immunological Methods|July 16, 1985
Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assaysR J Robb, P C Mayer, R Garlick
Cytokine|March 9, 2002
In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2M E Neville, R J Robb, M C Popescu
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Structure-function relationships for the IL 2-receptor system. II. Localization of an IL 2 binding site on high and low affinity receptorsL M Kuo, C M Rusk, R J Robb
The Journal of Clinical Investigation|August 1, 1987
Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetateS Chouaib, R J Robb, K Welte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activationJ D Ashwell, R J Robb, T R Malek
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responsesT R Malek, R J Robb, E M Shevach
The Journal of Experimental Medicine|August 1, 1992
Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2RS D Voss, P M Sondel, R J Robb
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complexT R Malek, R J Robb, E M Shevach
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983
Purification and partial sequence analysis of human T-cell growth factorR J Robb, R M Kutny, V Chowdhry
The Journal of Experimental Medicine|November 1, 1981
T cell growth factor receptors. Quantitation, specificity, and biological relevanceR J Robb, A Munck, K A Smith
Journal of Immunological Methods|July 16, 1985
Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assaysR J Robb, P C Mayer, R Garlick
Cytokine|March 9, 2002
In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2M E Neville, R J Robb, M C Popescu
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Structure-function relationships for the IL 2-receptor system. II. Localization of an IL 2 binding site on high and low affinity receptorsL M Kuo, C M Rusk, R J Robb
The Journal of Clinical Investigation|August 1, 1987
Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetateS Chouaib, R J Robb, K Welte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activationJ D Ashwell, R J Robb, T R Malek
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responsesT R Malek, R J Robb, E M Shevach
The Journal of Experimental Medicine|August 1, 1992
Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2RS D Voss, P M Sondel, R J Robb
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complexT R Malek, R J Robb, E M Shevach
Pageof 8